NHC — National HealthCare Corporation stock price and chart

NHC

$247.94+3.64%

as of close, Oct 20, 2026

☾ AH $247.94 +3.64%

National HealthCare CorporationStock · HealthcareRussell 2000 · 0.08% of IWMRussell 3000 · 0.004% of IWVUS Stock Market · 0.004% of VTI

PeersFMSSPYQQQNVDAAAPLMSFT

Share this page

Technical analysis2

Overlay lines0

Addendum charts0

VolumeDDDDDDDDDDDDDDDDDDDDDDDDDDDDEDEDEDEDEDEDEDEDEDEDEDD

20162019202120242026

60.080.0100.0120.0140.0160.0180.0200.0220.0240.002.0M$247.94

2026-10-20

Price$247.94

MA20$215.65

MA50$170.23

Vol489.7K

What would $1,000 invested in NHC be worth today? →

NHC returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $247.94
YTD price return: +80.86%
YTD total return: +82.71%
Next earnings: Nov 6, 2026
Market cap: 3.9B2016-12 1.1B2026-10 3.9B+238.2% over the window
Enterprise value: 3.9B
Shares outstanding: 15.7M2016-06 15.3M2026-06 15.7M+2.5% over the window
52W low: $118.14
52W high: $247.94
From 52W high: +0.00%
From 52W low: +109.87%
52W range: 100%

Volume

Rel volume: 1.23×
30D volume: 104.3K
30D $ vol: 23.8M

Fundamentals

Sales (ttm): 1.6B2016-12 923.6M2026-06 1.6B+68.8% over the window
Sales/share: $99.552016-12 $60.852026-06 $99.55+63.6% over the window
EPS (ttm): $8.902016-06 $3.402026-06 $8.90+161.7% over the window
FCF (ttm): 146.5M2016-06 7.8M2026-06 146.5M+1786.4% over the window
FCF/share: $9.362016-06 $0.512026-06 $9.36+1740.4% over the window
Book value/share: $71.662016-06 $43.952026-06 $71.66+63.0% over the window
Net margin: 9.00%2016-12 5.5%2026-06 9.0%+64.4% over the window
ROE: 12.50%2016-06 7.9%2026-06 12.5%+58.0% over the window
ROA: 9.13%2016-06 4.9%2026-06 9.1%+86.9% over the window
Debt / equity: 0.00×2016-06 0.182026-06 0.00-100.0% over the window
Current ratio: 1.862016-06 2.112026-06 1.86-11.8% over the window

Growth (CAGR, ttm) · 10Y

Sales: +6.92%2025-06-30 → 2026-06-301.5B → 1.6B (+6.9% total)+12.75%2023-06-30 → 2026-06-301.1B → 1.6B (+43.4% total)+8.76%2021-06-30 → 2026-06-301B → 1.6B (+52.2% total)+5.67%2016-12-31 → 2026-06-30923.6M → 1.6B (+68.8% total)
Net income: +33.87%2025-06-30 → 2026-06-30104.8M → 140.3M (+33.8% total)+63.76%2023-06-30 → 2026-06-3031.9M → 140.3M (+339.3% total)-3.38%2021-06-30 → 2026-06-30166.5M → 140.3M (-15.8% total)+10.20%2016-06-30 → 2026-06-3053.1M → 140.3M (+164.1% total)
FCF: +23.24%2025-06-30 → 2026-06-30118.9M → 146.5M (+23.2% total)+57.94%2023-06-30 → 2026-06-3037.2M → 146.5M (+294.1% total)+17.24%2021-06-30 → 2026-06-3066.2M → 146.5M (+121.5% total)+34.15%2016-06-30 → 2026-06-307.8M → 146.5M (+1786.4% total)
Shares: +1.04%2025-06-30 → 2026-06-3015.5M → 15.7M (+1.0% total)+0.74%2023-06-30 → 2026-06-3015.3M → 15.7M (+2.2% total)+0.31%2021-06-30 → 2026-06-3015.4M → 15.7M (+1.5% total)+0.25%2016-06-30 → 2026-06-3015.3M → 15.7M (+2.5% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: +32.73%2025-06-30 → 2026-06-30$6.71 → $8.90 (+32.7% total)+62.40%2023-06-30 → 2026-06-30$2.08 → $8.90 (+328.4% total)-3.84%2021-06-30 → 2026-06-30$10.82 → $8.90 (-17.8% total)+10.10%2016-06-30 → 2026-06-30$3.40 → $8.90 (+161.7% total)
Sales/share: +5.83%2025-06-30 → 2026-06-30$94.07 → $99.55 (+5.8% total)+11.93%2023-06-30 → 2026-06-30$70.99 → $99.55 (+40.2% total)+8.43%2021-06-30 → 2026-06-30$66.43 → $99.55 (+49.8% total)+5.32%2016-12-31 → 2026-06-30$60.85 → $99.55 (+63.6% total)
FCF/share: +21.98%2025-06-30 → 2026-06-30$7.67 → $9.36 (+22.0% total)+56.79%2023-06-30 → 2026-06-30$2.43 → $9.36 (+285.6% total)+16.88%2021-06-30 → 2026-06-30$4.29 → $9.36 (+118.1% total)+33.82%2016-06-30 → 2026-06-30$0.51 → $9.36 (+1740.4% total)
Book value/share: +8.71%2025-06-30 → 2026-06-30$65.93 → $71.66 (+8.7% total)+7.49%2023-06-30 → 2026-06-30$57.70 → $71.66 (+24.2% total)+4.04%2021-06-30 → 2026-06-30$58.80 → $71.66 (+21.9% total)+5.01%2016-06-30 → 2026-06-30$43.95 → $71.66 (+63.0% total)
Dividend/share: +4.86%2025-06-30 → 2026-06-30$2.47 → $2.59 (+4.9% total)+4.04%2023-06-30 → 2026-06-30$2.30 → $2.59 (+12.6% total)+4.48%2021-06-30 → 2026-06-30$2.08 → $2.59 (+24.5% total)+4.61%2016-06-30 → 2026-06-30$1.65 → $2.59 (+57.0% total)
Price: +100.97%2025-10-20 → 2026-10-20$123.43 → $247.94 (+100.9% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+55.05%2023-10-20 → 2026-10-20$66.50 → $247.94 (+272.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+28.61%2021-10-20 → 2026-10-20$70.48 → $247.94 (+251.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+14.20%2016-10-19 → 2026-10-20$65.73 → $247.94 (+277.2% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: +103.98%2025-10-20 → 2026-10-20$121.61 → $247.94 (+103.9% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+58.25%2023-10-20 → 2026-10-20$62.54 → $247.94 (+296.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+32.05%2021-10-20 → 2026-10-20$61.77 → $247.94 (+301.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+17.37%2016-10-19 → 2026-10-20$49.98 → $247.94 (+396.0% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 27.9×2016-12 22.232026-10 27.68+24.5% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 26.8×2016-12 18.202026-10 26.84+47.4% over the window
Fwd P/E: 564.7×
P/S (ttm)Market cap ÷ TTM revenue.: 2.5×2017-03 1.172026-10 2.49+112.3% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 3.5×2016-12 1.712026-10 3.46+102.1% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 26.5×2016-12 77.182026-10 26.50-65.7% over the window
EV/EBITDA (fy): 20.4×
EV/Sales (ttm): 2.5×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 3.77%2016-09 1.3%2026-06 4.4%+241.6% over the window
Dividend yield (fwd)Indicated annual dividend ÷ last close: the last regular payment × payments a year, from our own dividend record. Shown only for a company that pays the same amount each time (raises and cuts allowed), whose payments are on schedule and agree with the dividends it reports paying; a company whose payments vary in size, such as an unequal interim and final, has no forward figure — see the ttm yield.: 1.08%
Dividend yield (ttm)Dividends paid over the last year ÷ last close: the last full cycle of regular payments in our own dividend record. Below the forward yield after a raise, above it after a cut. Shown only when the record holds that full cycle and it agrees with the dividends the company reports paying; otherwise —.: 1.06%
Dividend/share (fwd)The indicated annual dividend: the last regular payment × payments a year, for a company that pays the same amount each time.: $2.68
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 15.7M ÷ 15.5M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: -1.04%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-1.04%) + dividends paid over that year ($39.8M) ÷ market_cap_at(2025-06-30) ($1.7B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: 1.36%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($4.7M) ÷ today's market cap ($3.9B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 0.12%2016-09 -0.4%2026-06 0.1%-138.1% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $4.7M + TTM dividends $39.8M) ÷ today's market cap ($3.9B). Same caveat as the cash buyback yield.: 1.15%2016-09 1.8%2026-06 1.3%-24.5% over the window

Vs own 10Y history

P/E: 80th
P/OI: 88th
P/S: 100th
P/B: 100th
P/FCF: 82nd

Bar = where today’s multiple sits in NHC’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-20#

+3.64%

+7.15%

+11.63%

+12.76%

YTD

+80.86%

+100.87%

+251.79%

Financial statements

Open full NHC financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+11.34%	+3.49%
JNJ	Johnson & Johnson	-3.94%	+2.19%
ABBV	AbbVie Inc.	+9.52%	+2.26%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	+11.24%	+3.04%
MRK	Merck & Co. Inc.	+0.97%	+3.25%
NVS	Novartis AG	+9.45%	+2.29%
TMO	Thermo Fisher Scientific Inc.	+5.51%	+1.18%
AMGN	Amgen Inc.	+13.82%	+3.29%

NHC — National HealthCare Corporation price, chart and key statistics